A evolução da farmacovigilância no Brasil - DOI: 10.4025/actascihealthsci.v27i2.1377

Késia Gemima Palma Rigo; Paula Nishiyama

doi:10.4025/actascihealthsci.v27i2.1377

The evolution of the pharmacovigilance in Brazil - DOI: 10.4025/actascihealthsci.v27i2.1377

Authors

Késia Gemima Palma Rigo UEM Author
Paula Nishiyama UEM Author

DOI:

https://doi.org/10.4025/actascihealthsci.v27i2.1377

Keywords:

farmacovigilância, eventos adversos, reação adversa a medicamentos

Abstract

This work makes a brief story on the conceptual aspects and the historical landmarks that involve the Pharmacovigilance. There are related the ways that had taken the development of the Pharmacovigilance in the world and Brazil, concluding with the perspectives of the development of a qualified service that will contribute to minimize the injury caused by drugs use and so serving to the public health and increasing the reliable sense of the patients in drugs use

Downloads

Download data is not yet available.

Author Biography

Paula Nishiyama, UEM

possui graduação em Farmácia pela Universidade Estadual de Maringá (1984), mestrado em Ciências Biológicas (Biologia Celular) pela Universidade Estadual de Maringá (1993) e doutorado em Saúde Coletiva pela Universidade Estadual de Campinas (2003). Atualmente é profesor adjunto da Universidade Estadual de Maringá. Tem experiência na área de Farmacologia, com ênfase em Toxicologia, atuando principalmente nos seguintes temas: intoxicações, farmacovigilância, análises toxicológicas, reações adversas a medicamentos e monitorização terapêutica Currículo Lattes

Downloads

PDF (Portuguese)

Published

2008-03-26

Issue

Vol. 27 No. 2 (2005)

Section

Pharmacy

License

DECLARATION OF ORIGINALITY AND COPYRIGHTS

I Declare that current article is original and has not been submitted for publication, in part or in whole, to any other national or international journal.

The copyrights belong exclusively to the authors. Published content is licensed under Creative Commons Attribution 4.0 (CC BY 4.0) guidelines, which allows sharing (copy and distribution of the material in any medium or format) and adaptation (remix, transform, and build upon the material) for any purpose, even commercially, under the terms of attribution.

Read this link for further information on how to use CC BY 4.0 properly.

How to Cite

Rigo, K. G. P., & Nishiyama, P. (2008). The evolution of the pharmacovigilance in Brazil - DOI: 10.4025/actascihealthsci.v27i2.1377. Acta Scientiarum. Health Sciences, 27(2), 131-135. https://doi.org/10.4025/actascihealthsci.v27i2.1377